Each year in the United States, the Centers for Disease Control estimates that at least 2 million people become infected with bacteria that are resistant to antibiotics, and at least 23,000 people die as a direct result of these infections.
On Sept. 18, 2014, the White House announced an Executive Order stating that the Federal Government will work domestically and internationally to detect, prevent, and control illness and death related to antibiotic-resistant infections by implementing measures that reduce the emergence and spread of antibiotic-resistant bacteria and help ensure the continued availability of effective therapeutics for the treatment of bacterial infections.
As antibiotic resistance has become a national and global public-health and security priority, top academic centers are preparing to launch ambitious programs addressing research on the basic, translational, and clinical aspects of antibiotic resistance.
The Division of Infectious Diseases at UTHealth has a strong track record of leadership and success in this field and seeks to leverage its robust research and clinical programs on antibiotic resistance. Most notably, the division is led by Dr. Barbara Murray, past president of the Infectious Diseases Society of America and current chair of its Antibiotic Resistance Committee. Dr. Cesar Arias, associate professor of internal medicine, is an international expert on antimicrobial resistance and conducts cutting-edge research on antimicrobial resistance in multi-national collaborative projects. Dr. Luis Ostrosky, professor and vice chair of medicine for quality, is a current member of the Food and Drug Administration Antimicrobial Advisor Committee and the medical director for antimicrobial stewardship at Memorial Hermann Texas Medical Center. Dr. Charles Ericsson, professor of internal medicine, is the director for antimicrobial stewardship and the formulary committee for Harris Health. Together they work to control antimicrobial resistance from the international to the local level.